MedTrace Logo

The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia

NCT01703104 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2012-10-10

No results posted yet for this study

Summary

The primary objective is to determine if there is a significant increase in the haematocrit value of patients on Jobelyn and standard therapy compared to those on standard therapy alone.

Conditions

Interventions

DRUG

Paludrine + Folic Acid

This is the combination of routine drugs for treating sickle cell disease

DIETARY_SUPPLEMENT

Paludrine + Folic Acid + Jobelyn

Combination of routine drugs + Jobelyn

Sponsors & Collaborators

  • Lagos State University

    lead OTHER

Principal Investigators

  • A O Dosunmu, M.D. · Lagos State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
14 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-03-31
Completion
2012-08-31

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01703104 on ClinicalTrials.gov